Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10909665 | Leukemia Research | 2005 | 7 Pages |
Abstract
Activating mutations or over-expression of the Flt3 is prevalent in acute myeloblastic leukemia (AML), associated with activation of Ras/MAP kinase and other signaling pathways. In this study, we addressed the role of Flt3 in the activation of nuclear factor-kappa B (NF-κB), which is a target molecule of these kinase pathways. In BaF3 cells stably expressing Flt3, a NF-κB-responsive reporter was upregulated and its target gene, IL-6, was increased by the involvement of Flt3-ERK/MAPK-NF-κB pathway. Furthermore, we found a modest positive correlation (r = 0.35, p = 0.096) between Flt3 and IL-6 mRNA expression in 24 AML specimens. These results suggest a role of Flt3 over-expression in NF-κB pathway.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shinichiro Takahashi, Hideo Harigae, Keiko Kumura Ishii, Mitsue Inomata, Tohru Fujiwara, Hisayuki Yokoyama, Kenichi Ishizawa, Junichi Kameoka, Jonathan D. Licht, Takeshi Sasaki, Mitsuo Kaku,